Insider Transactions in Q4 2022 at Optimize Rx Corp (OPRX)
Insider Transaction List (Q4 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 30
2022
|
Gus D Halas Director |
BUY
Exercise of conversion of derivative security
|
Direct |
409
+0.62%
|
-
|
|
Dec 30
2022
|
James Paul Lang Director |
BUY
Exercise of conversion of derivative security
|
Direct |
409
+1.03%
|
-
|
|
Dec 30
2022
|
Patrick D Spangler Director |
BUY
Exercise of conversion of derivative security
|
Direct |
409
+2.37%
|
-
|
|
Dec 30
2022
|
Ellen O'Connor Vos Director |
BUY
Exercise of conversion of derivative security
|
Direct |
409
+1.18%
|
-
|
|
Dec 30
2022
|
Gregory D Wasson Director |
BUY
Exercise of conversion of derivative security
|
Direct |
409
+2.14%
|
-
|
|
Nov 08
2022
|
Marion Odence Ford General Counsel and CCO |
SELL
Payment of exercise price or tax liability
|
Direct |
710
-10.46%
|
$9,940
$14.52 P/Share
|
|
Nov 08
2022
|
Marion Odence Ford General Counsel and CCO |
BUY
Exercise of conversion of derivative security
|
Direct |
1,785
+20.83%
|
-
|
|
Oct 11
2022
|
Edward Stelmakh CFO/COO |
BUY
Exercise of conversion of derivative security
|
Direct |
16,442
+33.35%
|
-
|
|
Oct 11
2022
|
Edward Stelmakh CFO/COO |
SELL
Payment of exercise price or tax liability
|
Direct |
6,539
-58.27%
|
$98,085
$15.17 P/Share
|